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AbstrAct
Objectives Prehospital intravenous access is a common 
intervention for patients with out-of-hospital cardiac 
arrest (OHCA). We aimed to assess the effectiveness 
of prehospital intravenous access and subsequent 
epinephrine administration on outcomes among OHCA 
patients.
Methods We conducted a prospective cohort study of 
patients with OHCA from non-traumatic causes aged 
≥18 years in Osaka, Japan from January 2005 through 
December 2012. The primary outcome was 1-month 
survival with favourable neurological outcome defined as 
a cerebral performance category of 1 or 2. The association 
between intravenous line placement and survival with 
favourable neurological outcome was evaluated by 
logistic regression, after propensity score matching for the 
intravenous access attempt stratified by initial documented 
rhythm of ventricular fibrillation (VF) or non-VF. The 
contribution of epinephrine administration to the outcome 
was also explored.
results Among OHCA patients during the study period, 
3208 VF patients and 38 175 non-VF patients were 
included in our analysis. Intravenous access attempt 
was negatively associated with 1-month survival with a 
favourable neurological outcome in VF group (OR 0.76, 
95% CI 0.59 to 0.98), while no association was observed 
in the non-VF group (OR 1.06, 95% CI 0.84 to 1.34). 
Epinephrine administration had no positive association 
in the VF patients (OR 0.75, 95% CI 0.51 to 1.07) and 
positively associated in the non-VF patients (OR 1.52, 
95% CI 1.08 to 2.08) with the favourable neurological 
outcome.
conclusions Intravenous access attempt could be 
negatively associated with survival with a favourable 
neurological outcome after OHCA. Subsequent epinephrine 
administration might be effective for non-VF OHCAs.
IntrOductIOn
Out-of-hospital cardiac arrest (OHCA) is one 
of the leading causes of death in the world.1 
In Japan, approximately 120 000 cardiac 
arrest events occur every year,2 and survival 
from OHCA remains low in spite of improve-
ments in the ‘chain of survival’ and the revi-
sion of cardiopulmonary resuscitation (CPR) 
guidelines.3–6 
There is little evidence to evaluate intra-
venous access and subsequent epinephrine 
administration for OHCAs with adjustment 
of inherent indications for intravenous line 
placement in actual prehospital settings. 
Current guidelines suggest that epineph-
rine be given during resuscitation of patients 
with OHCA with weak recommendation of 
very low-quality evidence.1 Although epineph-
rine is expected to have pharmacological 
effects as a potent vasoconstrictor and coro-
nary artery vasodilator during CPR,7 8 several 
studies have suggested poor neurological 
outcomes of epinephrine administration for 
OHCA patients in prehospital settings.9–11
In Japan, the emergency medical service 
(EMS) system is well-managed nationwide by 
the Fire and Disaster Management Agency 
and is operated by local fire departments. 
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strengths and limitations of this study
 ► Prospectively collected population-based data 
on intravenous access attempts.
 ► A propensity score matching of intravenous access 
attempts at the decision point of  emergency life-
saving technicians  (ELSTs) in the real world.
 ► Being lack of data on the skill level of ELSTs, 
the quality of cardiopulmonary resuscitation, 
information on in-hospital advanced measures after 
hospital arrival.
 ► The presence of unmeasured or unknown 
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Usually, each ambulance has a crew of three emergency 
providers including the emergency life-saving technicians 
(ELSTs), the most highly trained prehospital emergency 
care providers. EMS personnel provided advanced life 
support measures only for OHCA patients who did not 
get a return of spontaneous circulation (ROSC) after 
a series of basic life support measures such as chest 
compressions and defibrillations. ELSTs have been 
allowed to place a peripheral intravenous line since 1991, 
and specially trained and certified ELSTs were permitted 
to administer epinephrine following intravenous line 
placement in 2006.12 ELSTs administered epinephrine 
neither through the intraosseous (IO) route nor intratra-
cheal route but only through the intravenous access.
The aim of this study was to evaluate the effect of intra-
venous route access on favourable neurological outcomes 
after OHCA. The contribution of subsequent epineph-
rine administration to the outcomes was also explored.
MethOds
settings
This was a prospective population-based cohort study 
conducted in Osaka Prefecture, Japan from January 
2005 through December 2012. Osaka Prefecture had 
an area of approximately 1905 km2 and a population of 
approximately 8.8 million in 2014.13 14 There were 34 fire 
departments with dispatch centres in Osaka Prefecture, 
and municipal governments provided EMS. Do-not-re-
suscitate orders or living wills are not widely accepted in 
Japan, and EMS personnel are prohibited from termi-
nating resuscitation in the field. Therefore, all patients 
with OHCA who were treated by EMS personnel were 
transported to hospitals.
PArtIcIPAnts
The Utstein Osaka project was a prospective, popula-
tion-based registry system of OHCA based on the stan-
dardised Utstein-style reporting guidelines for cardiac 
arrests.15 16 Details of the project were published else-
where.3 We included all persons aged 18 years or over 
with OHCA of non-trauma origin. Among patients with 
initial rhythm of VF, we included only those who did 
not respond to the first defibrillation as those patients 
rarely have intravenous access attempt. Cardiac arrest was 
defined as the cessation of cardiac mechanical activities, 
as confirmed by the absence of signs of circulation.15
We collected data on ELSTs’ attempts of intravenous 
route access and their results. Throughout the study 
period, ELSTs were authorised to insert an intravenous 
route and to place advanced airway management devices 
on OHCA patients under online medical control direc-
tion when patients did not get ROSC after a series of 
basic life support procedures. They recorded the intra-
venous route to have been successfully placed when they 
could administer intravenous fluids by the access. If a 
patient had already had an intravenous route access made 
in a healthcare facility, they recorded the access as not to 
be attempted.
We also obtained variables including age, gender, loca-
tion of arrests, activity of daily living (ADL) before arrests, 
year, presence of bystander’s witness, details of bystand-
er-initiated CPR, medical control council (MC) in charge, 
epinephrine administration (yes, no), advanced airway 
management, origin of arrests (trauma, non-trauma) and 
initially documented rhythms.
Initial documented rhythm was recorded and diag-
nosed by the EMS personnel with semiautomated 
defibrillators on the scene and confirmed by the physi-
cian who was responsible for online medical direction. 
When laypersons delivered shocks using a public-access 
automated external defibrillator, the first documented 
rhythm was regarded as ventricular fibrillation (VF). The 
data form was filled out by the EMS personnel in cooper-
ation with physicians in charge of the patients and trans-
ferred to the Information Center for Emergency Medical 
Services of Osaka. When a data sheet was incomplete, 
it was completed by getting in contact with the relevant 
EMS personnel. Data on bystander CPR were obtained 
by the EMS observation and an interview with the witness 
before leaving the scene, by asking specific questions 
regarding the presence or absence of chest compressions 
and rescue breathing.
endPOInts
All survivors were followed for up to 1 month after the 
event by the EMS personnel in charge. Neurological 
outcome was determined by a follow-up interview to the 
EMS personnel in cooperation with the physicians in 
charge of the patient 1 month after successful resuscita-
tion, using the Cerebral Performance Category (CPC) 
scale17: category 1, good cerebral performance; category 
2, moderate cerebral disability; category 3, severe cere-
bral disability; category 4, coma or vegetative state; and 
category 5, death.
The primary outcome measure of this study was 1-month 
survival with a favourable neurological outcome, which 
was defined as CPC category 1 or 2. Secondary outcome 
measures included a ROSC before hospital arrival and 
1-month survival.
stAtIstIcAl MethOds
Baseline characteristics were summarised in numbers and 
percentages for categorical variables, and means and SD 
for continuous variables. All participants were divided 
into two groups according to their initially documented 
rhythms, VF or non-VF. Propensity scores (PS) modelling 
likelihood of intravenous access attempts compared with 
no attempt were calculated by fitting a logistic model with 
the following variables: year, age, gender, ADL, place, 
presence of bystander witness, bystander CPR details, 
MC, presence of a certificated ELST for epinephrine 
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variables included in the model were chosen as factors 
that may influence intravenous access attempt. As each 
MC cover different area and is trained differently for 
intravenous access attempt for OHCA, we included MC 
in the model to calculate PS. We performed PS matching 
in a one-to-one fashion between the intravenous access 
attempted group and the non-attempted group using 
callipers with a width equal to 0.2 of the SD of the logit 
of the PS.18 Covariate balances before and after matching 
were checked by comparing standardised mean differ-
ences. A standardised difference <10% was considered 
to indicate successful balancing.19 Logistic regression 
analyses were performed to assess the association of 
intravenous access attempt with the endpoints. We also 
exploratory analysed the association of successful intrave-
nous access placement, epinephrine administration and 
the endpoints. Moreover, ORs and their 95% CIs were 
calculated. All statistical analyses were performed using 
V.3.2.1 (R Foundation for Statistical Computing, Vienna, 
Austria).
ethIcs
The project protocol was approved by the institutional 
review board of Osaka University, with the approval of the 
EMS authorities and local governments in Osaka Prefec-




A total of 56 475 OHCAs were registered during the study 
period. Among them, 55 487 were adults aged 18 years 
or older, and 51 061 had resuscitation attempted by EMS. 
Among those 51 061, 46 904 OHCA patients had cardiac 
arrests before EMS arrival, 42 185 of which were non-trau-
matic cardiac arrests, and 42 051 ELSTs treated cardiac 
arrests. Among 3764 patients with initial rhythm of VF, 
556 patients responded to the first defibrillation, and 
the remaining 3208 patients were eligible to this study. 
Non-VF rhythm was documented in 38 175 (figure 1).
Patient characteristics and intravenous access attempt, 
success and epinephrine administration
Table 1A shows characteristics of eligible patients with 
VF rhythm, and table1B shows those of patients with 
non-VF rhythm. In the VF group, intravenous access was 
attempted in 1642/3208 (51.2%) and the success rate 
was 878/1642 (53.5%). In the non-VF group, intravenous 
access was attempted in 16 047/38 175 (42.0%) and the 
success rate was 7334/16 047 (45.7%). After PS matching, 
1802 patients of the VF group and 20 010 patients of 
the non-VF group were matched. Characteristics of the 
matched patients were presented in table 1A and 1B 
with successful matching. The area under the receiver 
operating characteristic curves of the logistic regression 
models (for the propensity of intravenous access attempt) 
was 0.81 for VF group and 0.82 for non-VF group.
Outcomes
Associations between intravenous route access, successful 
inttravenous route access placement, epinephrine 
administration and the favourable neurological outcome 
according to initially documented rhythms are shown in 
tables 2 and 3.
In the VF group (table 2), the intravenous route access 
attempt was negatively associated with 1-month survival 
with a favourable neurological outcome (OR 0.76, 95% CI 
0.59 to 0.98). Even when the intravenous route access was 
successfully established and epinephrine was adminis-
tered, the outcome was not improved (OR 0.87, 95% CI 
0.65 to 1.15). Failure of intravenous route access was asso-
ciated with worsening of the outcome (OR 0.61, 95% CI 
0.42 to 0.87). In regards to the secondary outcomes, 
successful intravenous route access was associated with 
higher rate of prehospital ROSC (OR 1.29, 95% CI 1.01 
to 1.65), and the failure of intravenous access had nega-
tive relation with achieving prehospital ROSC or survival 
at 1 month after cardiac arrest (OR 0.60, 95% CI 0.42 to 
0.83; OR 0.64, 95% CI 0.48 to 0.86). In turn, epinephrine 
administration has not been proved to increase prehos-
pital ROSC or 1-month survival (OR 1.32, 95% CI 0.98 to 
1.76; OR 1.00, 95% CI 0.75 to 1.33) among the matched 
patients with an initial rhythm of VF.
In the non-VF group (table 3), intravenous access 
attempt, its success or failure were not found to have a 
favourable relationship with the outcome (OR 1.06, 
95% CI 0.84 to 1.34, OR 1.17, 95% CI 0.89 to 1.54 and OR 
0.91, 95% CI 0.66 to 1.25). However, when the intravenous 
route access was successfully established and epinephrine 
was administered, the outcome was improved (OR 1.52, 
95% CI 1.08 to 2.08). The intravenous access attempt (OR 
2.41, 95% CI 2.16 to 2.69; OR 1.19 95% CI 1.04 to 1.36), 
successful intravenous access (OR 3.91, 95% CI 3.49 to 
4.38; OR 1.39, 95% CI 1.20 to 1.62) and epinephrine 
administration (OR 10.30, 95% CI 9.22 to 11.51; OR 2.81, 
95% CI 1.84 to 2.58) were all positively related to achieve 
prehospital ROSC and 1-month survival.
dIscussIOn
This study aimed to evaluate the effectiveness of prehos-
pital intravenous access for survival with neurologically 
favourable outcomes among VF and non-VF OHCAs, 
considering the attempt and success of intravenous 
access by EMS personnel based on a large-scale prospec-
tive population-based OHCA registry. The success rate 
of intravenous access was low and intravenous access 
attempted among VF OHCA patients was negatively 
related to 1-month survival with favourable neurolog-
ical outcome, even after a propensity score matching.
When EMS personnel administer epinephrine to the 
patients, the procedure includes three steps; intrave-
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Figure 1 Flowchart of the study. EMS, emergency medical service; ELST, emergency life-saving technician; VF, ventricular 
fibrillation.
route and epinephrine administration. The effective-
ness of epinephrine administration during resuscitation 
should depend on the success rate of the intravenous route 
attempt and interruption of CPR, in addition to the 
epinephrine’s pharmacological effect. We performed an 
analysis of the association between an intravenous route 
access ‘attempt’ and patients' outcomes, reflecting a deci-
sion-making process in the real world and demonstrated 
low survival in the intravenous access attempted among 
VF patients, but high survival in those among the non-VF 
group receiving epinephrine administration. The low 
success rate of the intravenous route attempt in this study 
(46%) was almost the same as with a previous study.20 As 
it is difficult to provide advanced treatments with high-
quality CPR especially in prehospital settings,1 we should 
discuss that advanced life support measures might not 
always help survival.
Intravenous access and epinephrine administration in OhcA 
(success rate, association with outcomes)
The effects of epinephrine administration on OHCA 
patients have been vigorously discussed for decades. A 
recent large randomised controlled trial (RCT) showed 
that patients with intravenous drug administration had 
no statistically significant improvement in survival to 
hospital discharge or 1-year survival.21 A large obser-
vational study from Japan that showed prehospital 
epinephrine had a negative association with favourable 
neurological outcomes at 1 month.10 On the other hand, 
Jacob’s RCT showed statistically significant improve-
ment in the proportion of patients achieving prehos-
pital ROSC, though failed to show statistically significant 
improvement in a survival to hospital discharge due to 
inadequate number of patient recruitment.22 Some 
























pen: first published as 10.1136/bm






 5Fujii T, et al. BMJ Open 2017;7:e015055. doi:10.1136/bmjopen-2016-015055
Open Access












Age, y, mean (SD) 64.8 (14.5) 65.1 (14.7) 0.021 64.6 (14.4) 64.9 (14.8) 0.018
Male, n (%) 1190 (76.1) 1287 (78.5) 0.058 687 (76.2) 694 (77.0) 0.018
Location of arrests, n (%) 0.084 0.070
Home 882 (56.3) 868 (52.9) 507 (56.3) 492 (54.6)
Public space 419 (26.8) 474 (28.9) 244 (27.1) 253 (28.1)
Work place 101 (6.4) 130 (7.9) 59 (6.5) 59 (6.5)
Healthcare facility 77 (4.9) 76 (4.6) 46 (5.1) 40 (4.4)
Others 87 (5.6) 94 (5.7) 45 (5.0) 57 (6.3)
Activity of daily living before arrests, n 
(%)
0.097 0.075
Good 1420 (90.7) 1454 (88.6) 808 (89.7) 807 (89.6)
Moderate 59 (3.8) 57 (3.5) 37 (4.1) 27 (3.0)
Poor 87 (5.6) 131 (8.0) 56 (6.2) 67 (7.4)
Year, n (%) 0.261 0.055
  2005 229 (14.6) 133 (8.1) 119 (13.2) 113 (12.5)
  2006 235 (15.0) 177 (10.8) 120 (13.3) 123 (13.7)
  2007 173 (11.0) 198 (12.1) 95 (10.5) 100 (11.1)
  2008 204 (13.0) 253 (15.4) 119 (13.2) 119 (13.2)
  2009 193 (12.3) 236 (14.4) 120 (13.3) 128 (14.2)
  2010 181 (11.6) 223 (13.6) 112 (12.4) 118 (13.1)
  2011 162 (10.3) 196 (11.9) 109 (12.1) 100 (11.1)
  2012 189 (12.1) 226 (13.8) 107 (11.9) 100 (11.1)
  Bystander-witnessed, n (%) 1069 (68.3) 1168 (71.1) 0.062 630 (69.9) 630 (69.9) <0.001
Bystander-initiated CPR, n (%) 0.024 0.055
  Compression-only CPR 397 (25.4) 419 (25.5) 212 (23.5) 230 (25.5)
  Conventional CPR 247 (15.8) 245 (14.9) 149 (16.5) 136 (15.1)
  No CPR 922 (58.9) 978 (59.6) 540 (59.9) 535 (59.4)
Medical control council, n (%) 0.755 0.090
  MC1 89 (5.7) 176 (10.7) 62 (6.9) 71 (7.9)
  MC2 90 (5.7) 123 (7.5) 78 (8.7) 75 (8.3)
  MC3 253 (16.2) 134 (8.2) 86 (9.5) 94 (10.4)
  MC4 114 (7.3) 150 (9.1) 82 (9.1) 66 (7.3)
  MC5 79 (5.0) 107 (6.5) 65 (7.2) 57 (6.3)
  MC6 252 (16.1) 65 (4.0) 54 (6.0) 59 (6.5)
  MC7 230 (14.7) 55 (3.3) 57 (6.3) 54 (6.0)
  MC8 459 (29.3) 832 (50.7) 417 (46.3) 425 (47.2)
Certified ELST attended, n (%) 616 (39.3) 1124 (68.5) 0.611 433 (48.1) 439 (48.7) 0.013
Airway management, n (%) 0.727 0.036
  Tracheal intubation 214 (13.7) 559 (34.0) 162 (18.0) 173 (19.2)
  LMA or OOA 639 (40.8) 815 (49.6) 494 (54.8) 480 (53.3)
  Bag valve mask 713 (45.5) 268 (16.3) 245 (27.2) 248 (27.5)
CPR, cardiopulmonary resuscitation; ELST, emergency life-saving technician; LMA, laryngeal mask airway; MC, medical control council; OOA, 
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Table 1B Patient characteristics with initial rhythm of non-VF according to intravenous access attempt after propensity score 
matching









Age, year, mean (SD) 75.1 (14.8) 74.6 (14.4) 0.036 74.5 (15.0) 73.6 (14.6) 0.056
Male, n (%) 11 791 (53.3) 9002 (56.1) 0.057 5536 (55.3) 5672 (56.7) 0.027
Location of arrests, n (%) 0.111 0.039
  Home 16 208 (73.2) 11 569 (72.1) 7275 (72.7) 7201 (72.0)
  Public space 1497 (6.8) 1499 (9.3) 852 (8.5) 925 (9.2)
  Workplace 284 (1.3) 285 (1.8) 163 (1.6) 182 (1.8)
  Healthcare facility 3416 (15.4) 2194 (13.7) 1412 (14.1) 1357 (13.6)
Others 723 (3.3) 500 (3.1) 303 (3.0) 340 (3.4)
Activity of daily living before 
arrests, n (%) 0.147 0.032
  Good 16 910 (76.4) 13 117 (81.7) 7996 (79.9) 8109 (81.0)
  Moderate 4037 (18.2) 2079 (13.0) 1459 (14.6) 1351 (13.5)
  Poor 1181 (5.3) 851 (5.3) 550 (5.5) 545 (5.4)
Year, n (%) 0.258 0.060
  2005 3078 (13.9) 1118 (7.0) 1228 (12.3) 1092 (10.9)
  2006 2576 (11.6) 1608 (10.0) 1239 (12.4) 1216 (12.2)
  2007 2464 (11.1) 1971 (12.3) 1279 (12.8) 1266 (12.7)
  2008 2603 (11.8) 2277 (14.2) 1337 (13.4) 1276 (12.8)
  2009 2472 (11.2) 2321 (14.5) 1216 (12.2) 1268 (12.7)
  2010 2677 (12.1) 2229 (13.9) 1175 (11.7) 1174 (11.7)
  2011 3059 (13.8) 2255 (14.1) 1267 (12.7) 1325 (13.2)
  2012 3199 (14.5) 2268 (14.1) 1264 (12.6) 1388 (13.9)
  Bystander witnessed, n (%) 6947 (31.4) 6407 (39.9) 0.179 3588 (35.9) 4063 (40.6) 0.098
  Bystander-initiated CPR, n 
(%) 0.009 0.008
  Compression-only CPR 6074 (27.4) 4383 (27.3) 2623 (26.2) 2609 (26.1)
  Conventional CPR 3185 (14.4) 2270 (14.1) 1497 (15.0) 1476 (14.8)
  No CPR 12 869 (58.2) 9394 (58.5) 5885 (58.8) 5920 (59.2)
Medical control council, n (%) 0.788 0.039
  MC1 1476 (6.7) 2142 (13.3) 1028 (10.3) 1050 (10.5)
  MC2 1442 (6.5) 1248 (7.8) 749 (7.5) 790 (7.9)
  MC3 3484 (15.7) 1400 (8.7) 1106 (11.1) 1108 (11.1)
  MC4 1868 (8.4) 1820 (11.3) 1145 (11.4) 1031 (10.3)
  MC5 1424 (6.4) 1300 (8.1) 810 (8.1) 804 (8.0)
  MC6 3200 (14.5) 400 (2.5) 393 (3.9) 400 (4.0)
  MC7 3327 (15.0) 436 (2.7) 426 (4.3) 436 (4.4)
  MC8 5907 (26.7) 7301 (45.5) 4348 (43.5) 4386 (43.8)
Certified ELST attended, n (%) 10 086 (45.6) 10 925 (68.1) 0.466 5033 (50.3) 5199 (52.0) 0.033
Airway management, n (%) 0.903 0.021
  Tracheal intubation 3205 (14.5) 6018 (37.5) 2385 (23.8) 2405 (24.0)
  LMA or OOA 7432 (33.6) 7707 (48.0) 5378 (53.8) 5283 (52.8)
  Bag valve mask 11 491 (51.9) 2322 (14.5) 2242 (22.4) 2317 (23.2)
CPR, cardiopulmonary resuscitation; ELST, emergency life-saving technician; LMA, laryngeal mask airway; MC, Medical Control Council; 
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Table 2 ORs for CPC 1 or 2 at 1 month before and after PS matching, and prehospital ROSC and 1-month survival for 






versus not administered 
(reference)Not attempted Succeeded Failed
CPC 1 or 2
—Before matching, 
n, (%) 272/1566 (17.4) 207/1642 (12.6) 131/878 (14.9) 76/764 (10.0) 71/579 (12.2)
OR (95% CI) 1.0 (reference)
0.69 (0.56 to 
0.83) — — —
1.0 (reference) — 0.84 (0.66, 1.05) 0.52 (0.40, 0.68)
— — — — 0.76 (0.58, 0.99)
CPC 1 or 2
—After matching, 
n, (%) 164/901 (18.2) 131/901 (14.5) 88/542 (16.2) 43/359 (12.0) 38/286 (13.3)
OR (95% CI) 1.0 (reference) 0.76 (0.59, 0.98) — — —
1.0 (reference) — 0.87 (0.65, 1.15) 0.61 (0.42, 0.87) —
— — — — 0.75 (0.51, 1.07)
Prehospital ROSC, 
n, (%) 199/901 (22.1) 197/901 (21.9) 145/542 (26.8) 52/359 (14.5) 75/286 (26.2)
OR (95% CI) 1.0 (reference) 0.99 (0.79, 1.23) — — —
1.0 (reference) — 1.29 (1.01, 1.65) 0.60 (0.42, 0.83) —
— — — — 1.32 (0.98, 1.76)
1-month survival, 
n, (%) 256/901 (28.4) 229/901 (25.4) 156/542 (28.8) 73/359 (20.3) 77/286 (26.9)
OR (95% CI) 1.0 (reference) 0.86 (0.70, 1.06) — — —
1.0 (reference) — 1.02 (0.80, 1.29) 0.64 (0.48, 0.86) —
— — — — 1.00 (0.75, 1.33)
CPC, cerebral performance category; PS, propensity score; ROSC, return of spontaneous circulation; VF, ventricular fibrillation.
administration of epinephrine might be effective for both 
initially unshockable23 and shockable rhythms.24 In our 
matched population, none of the patients with initial 
unshockable rhythms received epinephrine early in the 
time course, so we could not evaluate the effectiveness of 
early epinephrine administration. IO access would realise 
a higher success rate and make more rapid drug infusion 
possible than intravenous access during cardiac arrest, as 
previously reported,25 and might yield some additional 
benefits from epinephrine administration.
When we investigate the role of epinephrine in real 
prehospital OHCA settings, we should consider the 
intravenous access attempt, success and use rate before 
epinephrine administration. A report from national data 
of all OHCAs in Japan showed an association between 
intravenous route access and the decreased likelihood of 
a favourable neurological outcome.26 It matched patients 
who received prehospital intravenous fluids with those 
who did not receive intravenous fluids. Considering that 
the success rate of intravenous access attempt is not so 
high in general, there might have been two different 
types of patients among those who did not receive intra-
venous fluids; those for whom an intravenous access had 
been attempted but failed and an intravenous access had 
never been attempted. We prospectively collected data 
on intravenous access attempts to address this issue and 
calculated the propensity of intravenous access attempts 
at the decision point of ELSTs in the real world.
There are two reasons for placing an intravenous access 
in resuscitation: the delivery of pharmacological therapy 
and volume loading. For the latter, a previous study of 
paediatric OHCA reported that intravenous or IO access 
attempts and fluid administration were associated with 
improved survival.27 However, few studies have demon-
strated the advantage of prehospital intravenous access 
in adult patients. There might be several reasons why we 
could not find the beneficial effects of intravenous route 
attempts on neurological outcome. First, procedures 
related to intravenous access and epinephrine adminis-
tration might have led to a decline in the quality of chest 
compressions such as compression fraction and depth, 
which are keys to survival after OHCA.1 Second, delayed 
scene time might impact patient outcomes. A few studies 
have reported that the scene time had an association with 
patients’ outcomes.27 28 In our study, we found a 4 min 
delay from emergency call to hospital arrival. While the 
clinical effectiveness of many prehospital advanced life 
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Table 3 OR for CPC 1 or 2 at 1 month before and after PS matching and prehospital ROSC and 1-month survival for matched 






versus not administered 
(reference)Not attempted Succeeded Failed
CPC 1 or 2
—Before matching, 
n, (%) 291/22114 (13.5) 143/16040 (0.9) 89/7334 (1.2) 54/8706 (0.6) 44/3030 (1.4)
OR (95% CI) 1.0 (reference) 0.67 (0.55 to 0.82) — — —
1.0 (reference) — 0.92 (0.72, 1.16) 0.47 (0.35, 0.62) —
— — — — 1.31 (0.95, 1.77)
CPC 1 or 2
—After matching, 
n, (%) 135/10005 (1.3) 143/10005 (1.4) 89/5627 (1.6) 54/4378 (1.2) 44/2217 (2.0)
OR (95% CI) 1.0 (reference) 1.06 (0.84 to 1.34) — — —
1.0 (reference) —
1.17 (0.89 to 
1.54) 0.91 (0.66 to 1.25) —
— — — — 1.52 (1.08, 2.08)
Prehospital ROSC, 
n, (%) 501/10 005 (5.0) 1127/10 005 (11.3) 961/5627 (17.1) 166/4378 (3.8) 764/2217 (34.5)
OR (95% CI) 1.0 (reference) 2.41 (2.16 to 2.69) — — —
1.0 (reference) —
3.91 (3.49 to 
4.38) 0.75 (0.62 to0.89) —
— — — — 10.30 (9.22, 11.51)
1-month survival, 
n, (%) 412/10 005 (4.1) 485/10 005 (4.8) 318/5627 (5.7) 167/4378 (3.8) 185/2217 (8.3)
OR (95% CI) 1.0 (reference) 1.19 (1.04, 1.36) — — —
1.0 (reference) —
1.39 (1.20 to 
1.62) 0.92 (0.77 to 1.11) –
— — — — 2.18 (1.84, 2.58)
CPC, cerebral performance category; PS, propensity score; ROSC, return of spontaneous circulation; VF, ventricular fibrillation.
effectiveness of each procedure should be discussed in 
light of the sequence and time course of procedures.
limitations
Several inherent limitations to our study must be noted. 
First, we did not obtain data on the skill level of ELSTs and 
the quality of CPR such as compression rate and depth, 
which could have influenced on the outcomes. Second, we 
did not collect data on the timing of the prehospital ROSC 
and intravenous attempt. We have excluded patients who 
responded to the first defibrillation, as these patients rarely 
receive intravenous attempt. However, this exclusion crite-
rion partly adjusted comparability only among VF patients. 
In non-VF patients, we could not discriminate the patients 
who achieved ROSC in the very early timing of the CPR 
and did not have intravenous access attempted from those 
who did not achieve ROSC and did not have intravenous 
attempted for any reason. Third, our data did not include 
information on in-hospital advanced measures after hospital 
arrival. We could not address whether prehospital intrave-
nous access contributed to treatment after hospital arrival 
such as early administration of medications or therapeutic 
hypothermia. Fourth, this study did not assign intravenous 
access attempts randomly. We performed propensity score 
matching to improve comparability, but could not control 
unmeasured or unknown confounding factors that may 
have influenced the results. Of note, EMS personnel in 
Japan are prohibited from terminating CPR at their own 
discretion, which could impose substantial bias on the inter-
pretation of the result. Intravenous access could have been 
attempted only for those patients that EMS personnel and 
online MC personnel in charge judged as to be worth going 
forward with advanced procedures. Although we adjusted 
with available data, including bystander witness and MC, 
the results could be biased by unmeasured confounders, 
including the competency of providers, the quality of resus-
citation attempts and prolonged downtime. Given that the 
effect sizes observed in the present study are relatively small, 
the results must be cautiously interpreted for their fragility. 
Fifth, our analyses were primarily intended to evaluate the 
effectiveness of intravenous access. As patients’ outcome 
could be strongly influenced by the epinephrine adminis-
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administration. However, the results should be taken as 
exploratory considering that the PS model was constructed 
for intravenous access attempt, not for epinephrine adminis-
tration. We have noticed that there is a high profile ongoing 
double-blind, randomised controlled study, Prehospital 
Assessment of the Role of Adrenaline: Measuring the 
Effectiveness of Drug administration In Cardiac arrest 
that investigates the clinical efficacy and cost-effectiveness 
of epinephrine administration for patients with OHCA.31 
Gathering all the results from the RCT and observational 
studies would contribute in renewing the clinical practice 
guideline. Finally, this study was performed only in Osaka 
Prefecture in Japan. These results might not be applicable 
directly to other regions.
cOnclusIOns
Intravenous access attempts could be negatively associ-
ated with 1-month survival with a favourable neurological 
outcome after OHCA. Subsequent epinephrine adminis-
tration might be effective for initial non-VF OHCAs.
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